Page 105 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 105
Joint Workshop: EASL-EFSUMB Lecture 2 (Cont.) Stolz 2
12:25 - 12:35 Discussion
12:35 - 12:55 Indications to biopsy in diffuse liver disease in 2015 and
pathology reports
Massimo Pinzani, The United Kingdom
12:55 - 13:00 Discussion
ePoster Oral Sessions Hall B (ePoster Area) SCIENTIFIC PROGRAMME
13:00 - 14:00 Oral ePoster 1 Molecular and cellular biology
Catherine Postic, France
Oral ePoster 2 Transplantation and acute liver failure
Giacomo Germani, Italy
Oral ePoster 3 Liver fibrosis, Nanomedicine and new technologies
Klaas Poelstra, The Netherlands
Oral ePoster 4 Autoimmune liver disease
Marco Marzioni, Italy
Clinical Symposium - Future of HBV treatments Hall D
Chair:
Fabien Zoulim, France
14:00 - 14:20 The current treatment situation and definitions of a cure for
14:20 - 14:40 chronic HBV infection
14:40 - 15:00 Geoffrey Dusheiko, The United Kingdom
15:00 - 15:30
The main unresolved questions to cure HBV infection
Ulrike Protzer, Germany
The new direct antivirals in pre-clinical and early clinical
development
Fabien Zoulim, France
Novel concepts of immune therapy (restoration of innate and/or
adaptive immune responses)
Antonio Bertoletti, Singapore
Vienna, Austria • April 22–26, 2015 105
12:25 - 12:35 Discussion
12:35 - 12:55 Indications to biopsy in diffuse liver disease in 2015 and
pathology reports
Massimo Pinzani, The United Kingdom
12:55 - 13:00 Discussion
ePoster Oral Sessions Hall B (ePoster Area) SCIENTIFIC PROGRAMME
13:00 - 14:00 Oral ePoster 1 Molecular and cellular biology
Catherine Postic, France
Oral ePoster 2 Transplantation and acute liver failure
Giacomo Germani, Italy
Oral ePoster 3 Liver fibrosis, Nanomedicine and new technologies
Klaas Poelstra, The Netherlands
Oral ePoster 4 Autoimmune liver disease
Marco Marzioni, Italy
Clinical Symposium - Future of HBV treatments Hall D
Chair:
Fabien Zoulim, France
14:00 - 14:20 The current treatment situation and definitions of a cure for
14:20 - 14:40 chronic HBV infection
14:40 - 15:00 Geoffrey Dusheiko, The United Kingdom
15:00 - 15:30
The main unresolved questions to cure HBV infection
Ulrike Protzer, Germany
The new direct antivirals in pre-clinical and early clinical
development
Fabien Zoulim, France
Novel concepts of immune therapy (restoration of innate and/or
adaptive immune responses)
Antonio Bertoletti, Singapore
Vienna, Austria • April 22–26, 2015 105